Transferrin-Decorated Protein-Lipid Hybrid Nanoparticle Efficiently Delivers Cisplatin and Docetaxel for Targeted Lung Cancer Treatment

PURPOSE: Non-small cell lung cancer (NSCLC) therapy faces the barriers including drug resistance. A transferrin-functionalized protein-lipid hybrid nanoparticle (PLHN) was designed loading both cisplatin (CIS) and docetaxel (DTX) for the lung cancer treatment. METHODS: CIS and DTX were loaded into t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Kaiping, Zhang, Weina, Yu, Lan, Yu, Yi, Liu, Haixia, Zhang, Xiaotao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369919/
https://www.ncbi.nlm.nih.gov/pubmed/34413632
http://dx.doi.org/10.2147/DDDT.S296253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369919/
https://www.ncbi.nlm.nih.gov/pubmed/34413632
http://dx.doi.org/10.2147/DDDT.S296253

Ejemplares similares